MedTrace Logo

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

NCT00492479 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2007-12-24

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Conditions

  • Skin Aging

Interventions

DRUG

Kinerase Pro+Therapy Line day repair, serum, night repair

DRUG

Kinerase Pro+Therapy Line Ultra rich day repair

DRUG

LubriDerm

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Steven Yoelin, MD · Private Practice

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00492479 on ClinicalTrials.gov